Trial Outcomes & Findings for Active Powered Prosthesis (APEX) for Spinal Cord Injury (NCT NCT03696927)
NCT ID: NCT03696927
Last Updated: 2022-11-15
Results Overview
Users evaluate the usability and performance of the APEX device in completion of Activities of Daily Living (ADLs).
COMPLETED
NA
4 participants
Two hours of in-clinic prototype evaluation
2022-11-15
Participant Flow
Participant milestones
| Measure |
User Focus Group Participants
Human subjects with spinal cord injury at levels C3 to C5, and ASIA Impairment Scale (AIS) A, B, or C.
Active Powered Prosthesis (APEX) for Spinal Cord Injury: The Active Powered Prosthesis (APEX) is a proof-of-concept shoulder-elbow-wrist device intended to provide non-invasive active powered robotic assistive movement to upper extremities. Focus group participants will control the APEX device on a test manikin and provide feedback on the device design and function.
|
|---|---|
|
Overall Study
STARTED
|
4
|
|
Overall Study
COMPLETED
|
4
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Active Powered Prosthesis (APEX) for Spinal Cord Injury
Baseline characteristics by cohort
| Measure |
User Focus Group Participants
n=4 Participants
Human subjects with spinal cord injury at levels C3 to C5, and ASIA Impairment Scale (AIS) A, B, or C.
Active Powered Prosthesis (APEX) for Spinal Cord Injury: The Active Powered Prosthesis (APEX) is a proof-of-concept shoulder-elbow-wrist device intended to provide non-invasive active powered robotic assistive movement to upper extremities. Focus group participants will control the APEX device on a test manikin and provide feedback on the device design and function.
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
4 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
|
Sex: Female, Male
Female
|
1 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
3 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
1 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
3 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
4 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: Two hours of in-clinic prototype evaluationPopulation: Active Powered Prosthesis (APEX) for Spinal Cord Injury: The Active Powered Prosthesis (APEX) is a proof-of-concept shoulder-elbow-wrist device intended to provide non-invasive active powered robotic assistive movement to upper extremities. Focus group participants will control the APEX device on a test manikin and provide feedback on the device design and function. Functions assessed include ability to use voice control features and controlling device to mimic performance of ADLs.
Users evaluate the usability and performance of the APEX device in completion of Activities of Daily Living (ADLs).
Outcome measures
| Measure |
User Focus Group Participants
n=4 Participants
Human subjects with spinal cord injury at levels C3 to C5, and ASIA Impairment Scale (AIS) A, B, or C.
Active Powered Prosthesis (APEX) for Spinal Cord Injury: The Active Powered Prosthesis (APEX) is a proof-of-concept shoulder-elbow-wrist device intended to provide non-invasive active powered robotic assistive movement to upper extremities. Focus group participants will control the APEX device on a test manikin and provide feedback on the device design and function.
|
|---|---|
|
User Ability to Operate the APEX Device
Change Device Modes using Voice Control
|
4 Participants
|
|
User Ability to Operate the APEX Device
Control Device to Mimic ADL Performance on Manikin
|
4 Participants
|
Adverse Events
User Focus Group Participants
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Director of Clinical and Product Management
Abilitech Medical
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place